On behalf of the Microbiome First Virtual Summit planning committee, we warmly welcome you to this years event taking place at a Web browser near you. Whether you're logged in at your residence, the office or in the park somewhere, we feel privileged that you could join us.
Today, May 18, 2022 marks Day 2 of the 3 day event. We hope that you will enjoy this very special event.
Note: If you have a Twitter account you can follow along or ask questions at @Microbiomefirst or #MicrobiomeFirstSummit
* if you want to watch videos in full screen mouse over and click the "full screen" icon on the bottom right corner of the speakers video.
* You can also play "subtitles" in English by mousing over the "CC" icon also in the right bottom corner of the speakers video.
BENOIT CHASSAING, PHD
Principal Investigator, Chassaing Lab
Associate professor, French National Institute of Health and Medical Research.
Session: "Ubiquitous food additive and microbiota and intestinal environment"
PATRICIA MACCHIAVERNI, PHD
Clinical and translational researcher
Research Fellow, The University of Western Australia
Perth, WA, AUSTRALIA
Honorary Research Associate, Telethon Kids Institute.
Session: "House Dust Mite Shedding in Human Milk: a Neglected Cause of Allergy Susceptibility?"
CLAUDIA S. MILLER, MD, MS
Emeritus Professor, Allergy/Immunology and Environmental Health University of Texas San Antonio, TX, USA
Session: "Toxicant-Induced Lost of Tolerance for Chemicals, Foods and Drugs: a Global Phenomenon"
JAEYUN SUNG, PHD
Assistant Professor, Microbiome Program, Center for Individualized Medicine, Mayo Clinic.
Rochester, MN, USA
Session: "A predictive index for health status using species-level gut microbiome profiling"
MARTIN KRIEGEL, MD, PHD
Chief of Rheumatology and Clinical Immunology at University Hospital of Münster
Associate Professor Adjunct of Immunobiology at Yale School of Medicine.
Session: "Dietary Resistant Starch Effects on Gut Pathobiont Translocation and Systemic Autoimmunity"
EMMA HAMILTON-WILLIAMS, PHD
Principal Research Fellow
The University of Queensland Diamantina Institute
Faculty of Medicine
The University of Queensland
Translational Research Institute
Woolloongabba, QLD, AUSTRALIA
Session: "Metabolite-based Dietary Supplementation in Human Type 1 Diabetes is associated with Microbiota and Immune modulation"
SEI WON LEE, MD, PHD
College of Medicine, University of Ulsan
Department of Pulmonary and Critical Care, Asan Medical Center
Session: "The Therapeutic Application of Gut-Lung Axis in Chronic Respiratory Disease"
EMERAN A MAYER, MD
Gastroenterologist, Neuroscientist, Distinguished Research Professor
Department of Medicine, UCLA David Geffen School of Medicine
Executive Director, G. Oppenheimer Center for Neurobiology of Stress and Resilience at UCLA
Founding Director, UCLA Brain Gut Microbiome Center.
Los Angeles, CA, USA
Session: "The Gut–Brain Axis and the Microbiome: Mechanisms and Clinical Implications"
Day 2 Wrap-up